Allscripts announces second quarter 2016 results

Go back to Allscripts announces second quarter 2016 results

Allscripts (MDRX) PT Raised to $15 at Piper Jaffray

August 5, 2016 8:10 AM UTC

Piper Jaffray analyst Sean Wieland reiterated a Neutral rating but bumped his price target on Allscripts (NASDAQ: MDRX) to $15.00 (from $12.00) following record bookings driven by OptumCare win.

Wieland commented, "Allscripts beat bookings with the announcement of a win at OptumCare, a division of... More

Allscripts (MDRX) Reports In-Line Q2 EPS

August 4, 2016 4:04 PM UTC

Allscripts (NASDAQ: MDRX) reported Q2 EPS of $0.14, in-line with the analyst estimate of $0.14. Revenue for the quarter came in at $386.5 million versus the consensus estimate of $403.13 million.

For earnings history and earnings-related data on Allscripts (MDRX) click here.

... More